Abstract: The present application relates to perfume raw materials, perfume delivery systems and consumer products comprising such perfume raw materials and/or such perfume delivery systems, as well as processes for making and using such perfume raw materials, perfume delivery systems and consumer products. Such perfume raw materials and compositions, including the delivery systems, disclosed herein expand the perfume communities options as such perfume raw materials can provide variations on character and such compositions can provide desired odor profiles.

Abstract: The objective of the present invention is to provide a method for inhibiting polymerization of (meth)acrylic acid and the like. By the method, the generation of deposit in a pipe, which is exclusively used for providing a solution of a dialkyldithiocarbamic acid copper salt to a distillation column and the like, is prevented, and the problems such as the clogging of the pipe and polymerization in the distillation column are solved. The method according to the present invention for inhibiting polymerization of (meth)acrylic acid and/or an ester thereof is characterized in comprising a step of inhibiting polymerization of (meth)acrylic acid and/or the ester thereof by using a solution of a dialkyldithiocarbamic acid copper salt dissolved in an organic solvent, wherein a content amount of copper sulfate in the solution of the dialkyldithiocarbamic acid copper salt is 100 ppm or less by mass.

Abstract: The present invention provides a method for effectively preventing the precipitation related to manganese acetate in the pipe for sending a polymerization inhibitor and the like, and the polymerization of (meth)acrylic acid. A first method of the present invention for producing (meth)acrylic acid, characterized in comprising steps of: producing a (meth)acrylic acid-containing gas by catalytic vapor phase oxidation reaction; and obtaining a (meth)acrylic acid-containing fluid by providing the (meth)acrylic acid-containing gas into a condensation column or an absorption column; wherein manganese acetate is used as a polymerization inhibitor; manganese acetate is dissolved into a (meth)acrylic acid aqueous solution containing not more than 10% by mass of (meth)acrylic acid, and the like, to obtain a manganese acetate aqueous solution; and the manganese acetate aqueous solution is provided into the condensation column or the absorption column.

Abstract: The invention relates to a process for preparation of methacrylic acid, comprising the steps: a) providing a feed composition comprising a main compound selected from isobutylene and tert-butyl alcohol and at least one co-compound selected from the group consisting of methanol, dimethyl ether and formaldehyde; b) subjecting the feed composition provided in step a) with at least a first part of said at least one co-compound to a catalytic reaction zone and obtaining an oxidation phase comprising methyl methacrylate and methacrylic acid.

Abstract: A process is provided herein for the high yield production of high purity glacial methacrylic acid (“HPMAA”) that is substantially pure, specifically 99% pure or greater, with water content of 0.05% or less and low levels of other impurities, including HIBA, acrylic acid, MOMPA, methacrolein and others. This improved process comprises providing a crude MAA stream and purifying the crude methacrylic acid stream in a series of successive distillation steps involving two distillation columns. The inventive process is capable producing high purity methacrylic acid product that is especially suitable for the production of specialty MAA polymers.

Abstract: A medicament for prophylactic and/or therapeutic treatment of hepatic steatosis or non-alcoholic steatohepatitis, which comprises a polyprenyl compound (e.g., 3,7,11,15-tetramethyl-2,4,6,10,14-hexadecapentaenoic acid) as an active ingredient.

Abstract: The invention relates to a process for production of at least one C4 oxidation product, comprising the steps: a) providing a feed composition comprising at least two feed compounds selected from tert-butyl alcohol, methyl tert-butyl ether and isobutylene; b) subjecting the feed composition to a catalytic reaction zone comprising at least one oxidation stage and obtaining a reaction phase comprising the C4 oxidation product, to a C4 oxidation product obtainable therefrom, to an apparatus for production of at least one C4 oxidation product, a process carried out in the apparatus, to a methacrylic acid, to a polymer comprising methacrylic acid and process for production thereof, to methyl methacrylate and a process for production thereof, to a methacrylate ester and a process for production thereof, to a polymer comprising at least one of methacrylic acid, methyl methacrylate and a methacrylate ester and a process for production thereof, to a composition comprising at least one of methacrylic acid, methyl methac

Abstract: An allyl acetate production catalyst comprising at least (a) palladium, (b) gold, (c) a compound containing at least one element selected from copper, nickel, zinc and cobalt, (d) an alkali metal salt compound and (e) a carrier, is produced by a process comprising step 1 in which a homogeneous solution of a palladium-containing compound and a gold-containing compound is supported on a carrier by contact therewith, step 2 in which the carrier obtained in step 1 is contacted with an alkali solution for impregnation, step 3 in which the carrier obtained in step 2 is subjected to reduction treatment, and step 4 in which a compound containing at least one element selected from copper, nickel, zinc and cobalt and an alkali metal salt compound are supported onto the carrier obtained in step 3. The obtained allyl acetate production catalyst has minimal reduction in activity and improved selectivity, when used for production of allyl acetate from propylene, oxygen and acetic acid.

Abstract: An infection inhibitor of retrovirus, particularly human immunodeficiency virus, comprising, as an active ingredient, at least one compound selected from the group consisting of a compound represented by the formula (I) (GGA) or a salt thereof, a compound represented by the formula (II) (NIK-333) or a salt thereof, and derivatives thereof.

Abstract: A catalyst for the production of methacrylic acid comprising a heteropolyacid compound containing phosphorus and molybdenum is regenerated by a method comprising the steps of drying a mixture containing a deactivated catalyst, an ammonium ion, a nitrate ion and water, molding the dried mixture, firstly calcining the molded product in an atmosphere of an oxidizing gas at a temperature of 360 to 410° C., and then secondly calcining the product in an atmosphere of a non-oxidizing gas at a temperature of 420 to 500° C. The regenerated catalyst has substantially the same catalytic activity as a fresh catalyst in a gas phase catalytic oxidation reaction of methacrolein, isobutylaldehyde, isobutane or isobutyric acid to prepare methacrylic acid.

Abstract: The invention relates to methods of treating mucositis comprising administering a compound of formula A, compound of any one of formulae 1 to 46, lipoxin compound, or oxylipin compound.

Abstract: An object of the present invention is to provide a highly active catalyst for producing an unsaturated oxygen-containing compound from an alkane and the catalyst comprising Mo, V, Ti and Sb or Te as the indispensable active components. The preferable catalyst is represented by formula (1) or (2) as shown below, Mo1.0VaTibXcYdOe??(1) Mo1.0VaTibXcYdZfOe??(2) wherein X represents Sb or Te; Y represents Nb, W or Zr; Z represents Li, Na, K, Rb, Cs, Mg, Ca or Sr; a, b, c, d, e and f represent atomic ratios of their respective elements, with 0<a<0.7, 0<b<0.3, 0<c<0.7, 0?d<0.3, 0<f<0.1; e is a number determined by oxidation states of the other elements than oxygen.

Abstract: Skin lightening additives and skin lightening compositions having at least one of a heterosubstituted, saturated or unsaturated aliphatic acid are described. The compositions are suitable for topical application and may comprise 12-hydroxystearic acid, ricinoleic acid or both.

Abstract: An engineered strain of the oleaginous yeast Yarrowia lipolytica capable of producing greater than 5.6% docosahexaenoic acid acid (DHA, an w-3 polyunsaturated fatty acid) in the total oil fraction is described. This strain comprises various chimeric genes expressing heterologous desaturases, elongases and acyltransferases and optionally comprises various native desaturase and acyltransferase knockouts to enable synthesis and high accumulation of DHA. Production host cells are claimed, as are methods for producing DHA within said host cells.

Abstract: The present invention relates in general terms to a process for preparing acetone cyanohydrin, comprising as steps: A. contacting acetone and hydrocyanic acid in a reactor to give a reaction mixture, the reaction mixture being circulated, to obtain acetone cyanohydrin; B. cooling at least some of the reaction mixture by flowing it through a cooling region of a cooler, the cooler including one cooling element or at least two cooling elements; C.

Abstract: Disclosed is a method for producing an ?,?-unsaturated carboxylic acid by oxidizing an olefin or an ?,?-unsaturated aldehyde in a liquid phase in the presence of a noble metal catalyst, which can ensure operational safety at the time of stopping the reaction and prevent deterioration of the noble metal catalyst. The method for producing the ?,?-unsaturated carboxylic acid by an oxidation reaction in which the olefin or the ?,?-unsaturated aldehyde is oxidized in the liquid phase in the presence of the noble metal catalyst in a reactor, includes a step of stopping the oxidation reaction by supplying an inert gas to the reactor.

Abstract: A catalyst for use in the production of an unsaturated aldehyde and/or an unsaturated carboxylic acid, the catalyst comparing (or, preferably, being composed of) a mixed oxide containing molybdenum, bismuth and iron, which has improved mechanical strength, is produced by a method including the steps of (1) drying an aqueous solution or an aqueous slurry containing raw materials of the catalyst and then firstly calcining a dried product in a molecular oxygen-containing gas atmosphere to obtain a calcined product; (2) heating the calcined product obtained in Step (1) in the presence of a reducing material to obtain a reduced product having a mass loss of 0.05 to 6%; and (3) secondly calcining the reduced product obtained in Step (2) in a molecular oxygen-containing gas atmosphere.

Abstract: A one-step vapor phase oxidation process produces an unsaturated carboxylic acid, such as acrylic acid or methacrylic acid, from an alkane, such as propane or isobutane, with a mixed metal oxide catalyst and an excess of alkane relative to oxygen. The unreacted alkane and the byproduct alkene are recycled to the reaction zone without separation. Overall yield and productivity of the unsaturated carboxylic improves for such a process. An analogous method for the preparation of unsaturated nitrites is also disclosed.

Abstract: The present invention relates to a device for the preparation of acrylic acid, comprising a first reactor and at least one further reactor, wherein at least the first reactor is a multi-tube reactor having a plurality of tubes comprising a catalyst which catalyses the synthesis of acrolein, wherein the tubes open into a collection chamber which can be fluidically connected to the at least one further reactor via an outflow region, wherein the outflow region comprises a laminarization means causing laminarization of a flow profile of a gas flowing through the outflow region. The invention also relates to a process for the preparation of acrylic acid, to an acrylic acid, to a process for the preparation of a hydrophilic polymer, to a hydrophilic polymer, to a method for the production of a water-absorbent hygiene article, to chemical products, and to the use of an acrylic acid.

Abstract: L-carnitine calcium fumarate and its preparation and applications are disclosed in the present invention. Having good water solubility as well as better and stronger nutritious and treating functions than the corresponding inner salts, the L-carnitine calcium fumarate as proposed having the advantages of being non-hygroscopic, stable in chemical property, and suitable for oral administration. A preparing method is as follow: fumaric acid is suspended in water and calcium base is added. The resulting mixture is heated up to 70˜90° C. and kept under stirring for 2˜8 hours, and then concentrated under reduced pressure. The resulting dried substance is added into ethanol, and the mixture is vigorously stirred. The inner salt of L-carnitine is added, and the mixture is reacted for 1-6 hours at 60˜70° C. and then cooled for 2˜8 hours. L-carnitine calcium fumarate is obtained by filtration.

Abstract: The invention relates to a process for preparing chiral octenoic acid derivatives, which constitute important intermediates in the preparation of medicament active ingredients, and also to novel intermediates which are used in the process for preparing the octenoic acid derivatives mentioned.

Abstract: A process for storing a monomer phase which is liquid under the conditions of storage and comprises methacrylic monomers to an extent of ?95% by weight and has been obtained by condensation out of a gaseous phase or by melting a crystalline phase, in a storage vessel, in which polymer of the monomer present in dissolved form in the liquid monomer phase is removed therefrom on the route from its generation into the storage vessel, and also a process for withdrawing liquid monomer phase from the storage vessel in which polymer of the monomer present in dissolved form in the monomer phase is likewise removed.

Abstract: Dithiol compounds and derivatives thereof are disclosed. The agents are useful for treating ocular disease, especially presbyopia and cataract.

Abstract: Methods of preparing isoprenyl cysteine compounds by coupling a cysteine compound with an activated (i.e. halogenated) lipid are disclosed. Also disclosed, among other things, are methods of making activated (i.e. halogenated) lipids, and methods of purifying isoprenyl cysteine compounds.

Abstract: A process for preparing racemic alkyl-5-halopent-4-enecarboxylic acids and esters thereof of the formula (I), in which R is a C1-C6-alkyl radical, R1 is H or C1-4-alkyl and X is chlorine, bromine or iodine, which comprises a) reacting a dialkyl alkylmalonate of the formula (II),in which R is as defined above and R2 is a C1-C4-alkyl radical, in the presence of a metal alkoxide of the formula MOR3, in which M may be Na, K or Li, and R3 is a C1-C4-alkyl radical, and in an organic solvent, with 1,3-dihalopropene to give the corresponding allylated malonate, then b) after full conversion, adding an inorganic salt and a C1-C6 alcohol to the reaction mixture, heating the reaction mixture to reflux temperature, then c) isolating the desired racemic ester of the formula (I) from the reaction mixture by extraction or direct distillation and d) if the racemic acid is the desired end product, hydrolyzing the ester function.

Abstract: The invention provides a method of producing acrylic acid. The method includes contacting fumaric acid with a sufficient amount of ethylene in the presence of a cross-metathesis transformation catalyst to produce about two moles of acrylic acid per mole of fumaric acid. Also provided is an acrylate ester. The method includes contacting fumarate diester with a sufficient amount of ethylene in the presence of a cross-metathesis transformation catalyst to produce about two moles of acrylate ester per mole of fumarate diester. An integrated process for process for producing acrylic acid or acrylate ester is provided which couples bioproduction of fumaric acid with metathesis transformation. An acrylic acid and an acrylate ester production also is provided.

Abstract: Provided is a method for preparing (E3,Z5)-3,5-alkadienyl acetate and (E3,Z5)-3,5-dodecadienyl acetate which is a sex pheromone of Brazilian apple leafminer. Specifically, provided is a method for preparing (E3,Z5)-3,5-alkadienyl acetate, comprising steps of hydrolyzing 5,5-diethoxy-(Z3)-3-pentenyl methoxymethyl ether in the presence of an acid to obtain 4-formyl-(E3)-butenyl methoxymethyl ether; reacting the 4-formyl-(E3)-butenyl methoxymethyl ether with alkylidene triphenylphosphorane in accordance with the Wittig reaction to obtain (E3,Z5)-3,5-alkadienyl methoxymethyl ether; and obtaining (E3,Z5)-3,5-alkadienyl acetate using the (E3,Z5)-3,5-alkadienyl methoxymethyl ether as a starting substance.

Abstract: A process for purifying removal of crystals from their suspension in mother liquor by means of a washing column having forced transport in which the process chamber is encased by a metal wall which, on its side facing away from the process chamber, is heated at least along the length of the pure melt zone.

Abstract: Through hydrolysis of reaction products of polyethylene or Fischer-Tropsch waxes and ?,?-unsaturated carboxylic acids or their derivatives it is possible to gain access to innovative ionomer waxes which, in contrast to known ionomers of low molecular mass, exhibit low melt viscosities even at high degrees of hydrolysis. The ionomer waxes of the invention are suitable inter alia as components of pigment masterbatches, as plastics additives, and for application in polishes, paints, and printing inks.

Abstract: The present invention relates to lipid compounds of the general formula (I): wherein—n=0-2, —R1 and R2 are the same or different and may be selected from a group of substituents consisting of a hydrogen atom, an alkyl group, a halogen atom, and an alkoxy group; -, X is COR3 or CH2OR4, wherein —R3 is selected from the group consisting of hydrogen, hydroxy, alkoxy, and amino, —wherein X further comprises carboxylic acid derivatives when R3 is hydroxy and —R4 is selected from the group consisting of hydrogen, alkyl or acyl, —Y is a C9 to C21 alkene with one or more double bonds with E or Z configuration; or any pharmaceutically acceptable complex, solvate or pro-drug thereof. The present invention also relates to pharmaceutical compositions comprising such lipid compounds, and to such lipid compounds for use as medicaments or for diagnostic purposes.

Abstract: The present invention relates to a modified colored pigment comprising a colored pigment having an attached organic group. The organic group is attached to the colored pigment via at least one carbon atom of a C—C single bond or double bond, wherein the C—C single bond or double bond is not a component of an aromatic system. The organic group further comprises at least one activating group on at least one carbon atom of the C—C single bond or double bond. A method of preparing a modified colored pigment is also disclosed, as are aqueous and non-aqueous dispersions, e.g., including ink jet inks, comprising the modified colored pigments.

Abstract: The objective of the present invention is to provide methods of efficiently purifying and producing acrylic acid by removing solid acrylic acid polymers dissolving and existing in crude acrylic acid supplied to purifying process. The purifying method of the present invention comprises: filtrating the crude acrylic acid to obtain a filtrate at temperature from 15 to 70° C. and at liquid linear velocity of 5 m/s or less, wherein the crude acrylic acid contains an acrylic acid of 50% by mass or more; and purifying the acrylic acid from the filtrate. The producing method of the present invention comprises carrying out the purifying method.

Abstract: A method is provided herein for purifying (meth)acrylic acid to provide a purified (meth)acrylic acid product having a low aldehyde concentration and not more than 0.2 wt % water. One embodiment of the method includes distilling (meth)acrylic acid in the presence of an aldehyde treating compound. Another embodiment of the method includes also distilling crude (meth)acrylic acid in the presence of a reactive drying agent. (Meth)acrylic acid produced in this manner is especially suitable for use in specialty (meth)acrylic acid polymers, such as for example superabsorbent polymers, binders, and ethylene-(M)AA copolymers.

Abstract: The present invention relates to a process for the production of polymers, such as water-absorbing polymer structures, by radical polymerization of acrylic acid, whereby the acrylic acid has been obtained by a synthesis process which comprises as a process step the splitting of an organic material by means of an enzyme or at least one component of an enzyme. The invention also relates to the water-absorbing polymers obtainable by this process, water-absorbing polymers which are based to at least about 25 wt % upon partially neutralized acrylic acid, a composite, a process for the production of a composite, the composite obtainable by this production, the use of acrylic acid in the production of polymers, preferably in the production of water-absorbing polymer structures, a device for the production of acrylic acid, and a process for the production of acrylic acid.

Abstract: Disclosed is a method for synthesizing t-butyl (meth)acrylate at low cost. Specifically, disclosed is a method for synthesizing a carboxylic acid ester by performing an addition reaction between isobutylene and (meth)acrylic acid in the presence of an acidic catalyst. This method includes the steps of: (A) performing a dehydration decomposition reaction of t-butyl alcohol in the presence of a first acidic catalyst; (B) obtaining crude isobutylene gas by separating at least water from a produced gas obtained in the step A; (C) absorbing the crude isobutylene gas in an absorption solvent containing (meth)acrylic acid; and (D) producing t-butyl (meth)acrylate by performing the addition reaction by bringing the absorption solvent which has absorbed the crude isobutylene gas into contact with a second acidic catalyst.

Abstract: A process for transition metal-catalyzed, asymmetric hydrogenation of acrylic acid derivatives of the formula (I) in which R1 is H or an optionally substituted alkyl, aryl or heteroaryl radical, R2 is an optionally substituted alkyl, aryl or heteroaryl radical, and R3 is H or a C1-C6-alkyl radical, which comprises hydrogenating compounds of the formula (I), optionally in a solvent, in the presence of one or more hydrogen donors, using a catalyst system which comprises a transition metal from the group of ruthenium, rhodium and iridium and a combination of a chiral phosphorus ligand of the formula (II) in which Cn, together with the two oxygen atoms and the phosphorus atom, forms an optionally substituted ring having from 2 to 6 carbon atoms and R4 is an optionally substituted alkyl, aryl, alkoxy or aryloxy radical or NR5R6 where R5 and R6 may each independently be H or an optionally substituted alkyl, aryl, aralkyl or alkaryl radical, or, together with the nitrogen atom, may form a ring, and an achiral phosph

Abstract: An object of the present invention is to provide: a catalyst for production of acrylic acid which catalyst is so high active as to give a still higher selectivity of acrylic acid (which is the objective product) or a long-catalytic-life-time catalyst for production of acrylic acid which catalyst is so high active as to be able to give a high acrylic acid yield while suppressing the temperature rise of the oxidation reaction to a low one; and processes for production of acrylic acid using these catalysts.

Abstract: One aspect of the present invention is directed to a composition. The composition includes a dispersion inducer comprising: H3C—(CH2)n—CHmCHmR, where is a single or double carbon-carbon bond, m is 1 or 2, n is 2 to 15, and R is a carboxylic acid, a salt, an ester, or an amide, where the ester or amide is an isostere or biostere of the carboxylic acid. The composition additionally contains an additive component selected from one or more of the group consisting of biocides, surfactants, antibiotics, antiseptics, detergents, chelating agents, virulence factor inhibitors, gels, polymers, pastes, edible products, and chewable products. The composition is formulated so that when it is contacted with a biofilm produced by a microorganism, where the biofilm comprises a matrix and microorganism on a surface, the dispersion inducer selectively acts on the microorganism and has a suitable biological response without a required direct effect on the matrix to disperse the biofilm.

Abstract: It has now been found that after administration to a diseased person or person that is at risk for developing such disease of a neutraceutical or pharmaceutical composition that comprises a/ a lipid fraction comprising at least one of docosahexanoic acid (DHA), docosapentaenoic acid (DPA) and eicosapentaenoic acid (EPA); b/ a protein fraction comprising proteinaceous material from non-human origin which provide at least cysteine and/or taurine; and c/ a mineral fraction comprising at least one of manganese and molybdene, the health of these persons improves. Membrane function of several types of mammalian cells improves, which allows efficient treatment of immune related disorders, such as allergy, autoimmune diseases, cancer, cognitive dysfunction and other diseases of the nervous system, neuropathies, such as diabetic neuropathies and neuropathic pains, neuronal damage during insulin resistance, and gut diseases and support of the development of gut and lung function during growth or recovery.

Abstract: To provide a method for producing an optically active (4E)-5-chloro-2-isopropyl-4-pentenoic acid, a basic amino acid salt thereof or an optically active (4E)-5-chloro-2-isopropyl-4-pentenoic acid ester with high yield and high optical purity by simple operation. An optically active (4E)-5-chloro-2-isopropyl-4-pentenoic acid is obtained by precipitating a basic amino acid salt of optically active (4E)-5-chloro-2-isopropyl-4-pentenoic acid from a solvent solution containing an optical isomer mixture of (4E)-5-chloro-2-isopropyl-4-pentenoic acid and an optically active basic amino acid or a salt thereof, and then the basic amino acid salt of optically active (4E)-5-chloro-2-isopropyl-4-pentenoic acid is subjected to a desalting reaction. Further, an esterification reaction is carried out to obtain an optically active (4E)-5-chloro-2-isopropyl-4-pentenoic acid ester.

Abstract: The present invention provides a method for efficiently using an aqueous solution of (meth)acrylic acid at a low concentration formed in a production/storage step of (meth)acrylic acid. In the present invention, a (meth)acrylic acid derivative is produced by using as a raw material an aqueous solution of (meth)acrylic acid formed by one or both of: a device which reduces a pressure of a gas comprising (meth)acrylic acid in production of (meth)acrylic acid; and a device which collects (meth)acrylic acid from a gas comprising (meth)acrylic acid.

Abstract: The present invention relates to the use of an oil enriched in docosahexaenoic acid, which is conjugated to triglyceride, for manufacturing a pharmaceutical composition for the treatment of a tumorous disease, said oil being enriched in a concentration of up to 70% by weight in relation to the total weight of said pharmaceutical composition, and said docosahexaenoic acid being in a percentage of at least 50% in relation to the total fatty acids in said oil.

Abstract: A process for preparing racemic alkyl-5-halopent-4-enecarboxylic acids and esters thereof of the formula (I), in which R is a C1-C6-alkyl radical, R1 is H or C1-4-alkyl and X is chlorine, bromine or iodine, which comprises a) reacting a dialkyl alkylmalonate of the formula (II),in which R is as defined above and R2 is a C1-C4-alkyl radical, in the presence of a metal alkoxide of the formula MOR3, in which M may be Na, K or Li, and R3 is a C1-C4-alkyl radical, and in an organic solvent, with 1,3-dihalopropene to give the corresponding allylated malonate, then b) after full conversion, adding an inorganic salt and a C1-C6 alcohol to the reaction mixture, heating the reaction mixture to reflux temperature, then c) isolating the desired racemic ester of the formula (I) from the reaction mixture by extraction or direct distillation and d) if the racemic acid is the desired end product, hydrolyzing the ester function.

Abstract: A method for purifying a crude (meth)acrylic acid obtained by a vapor phase catalytic oxidation method, characterized in that the crude (meth)acrylic acid having most parts of water and acetic acid removed therefrom, is fed to and distilled in a first distillation column of a purification system comprising first to third three distillation columns, the top fraction from the first distillation column is fed to and distilled in the second distillation column, the resulting top fraction is recovered as a high purity (meth)acrylic acid product, the bottoms from the first and second distillation columns are fed to and distilled in the third distillation column, and the resulting top fraction is fed to the first distillation column.

Abstract: In the stopping and starting operations of a distillation column used for producing (meth)acrylic acids according to the present invention, upon stopping the operation of the distillation column, the heating of a reboiler attached thereto is interrupted and then the reboiler is rapidly cooled; and/or upon starting the operation of the distillation column for production of the (meth)acrylic acids, an inner wall surface of the distillation column is heated to a temperature higher than a condensation temperature of the (meth)acrylic acids and the operation of the distillation column is started under the heated condition. According to the present invention, it is possible to early and safely stop the operation of the distillation column while preventing the occurrence of polymerization within the distillation column, and stably perform an operation for distillation of acrylic monomers for a long period of time.

Abstract: The invention provides adamantane derivatives of formula (I), a process for their preparation, pharmaceutical compositions containing them, a process for preparing the pharmaceutical compositions, and their use in therapy. In formula (I) D represents CH2 or CH2CH2, E represents C(O)NH or NHC(O) and R3 represents a group of formula (I).

Abstract: An energy-curable polymer-forming composition for making a pressure sensitive adhesive includes an unsaturated oligomer resin and an adhesive promoter which increases the peel strength of the adhesive without reducing its tack. The composition also includes a tackifier and various other optional components such as photoinitiator, chain extender, reactive diluent and the like.

Abstract: The objective of the present invention is to provide method for acrylic acid in which a generation of polymerized substance is prevented while acrylic acid is stored in a storage tank. A method of the present invention for producing acrylic acid, comprising storing acrylic acid in a storage tank, wherein a process liquid containing 50 mass % or more of acrylic acid is subjected to at least one filtering operation at 15 to 70° C. when the process liquid is supplied to the storage tank.

Abstract: The present invention relates to a pharmaceutical co-crystal comprising an active pharmaceutical ingredient and a co-crystal agent having the structure R1—C(?O)XH.

Abstract: A ?,?-unsaturated carboxylic acid silyl ester is prepared by reacting an ?,?-unsaturated carboxylic acid ester with a hydrosilane or hydrosiloxane in the presence of tris(pentafluorophenyl)borane. ?,?-Unsaturated carboxylic acid derivatives are readily prepared through fewer steps and in high yields.